C-mo Medical Solutions: Comprehensive Company and Competitor Profile

Overview

C-mo Medical Solutions is a Portuguese digital health start-up dedicated to developing innovative solutions for cough diagnosis and management. The company addresses a crucial medical requirement by providing a wearable cough-monitoring device that aids in an extensive evaluation of cough characteristics. This device empowers healthcare professionals to enhance diagnostic precision and tailor treatment strategies effectively. C-mo aims to transform the methodologies of cough monitoring and management, promising a substantial impact across various medical applications.

Financial Information

C-mo Medical Solutions has garnered a total funding of $5.195 million in seed capital. Notable investors include Boehringer Ingelheim Venture Fund, Portugal Ventures, and High-Tech Gründerfonds. These investments are pivotal in advancing product development and facilitating entry into the European and U.S. markets.

Management Team

Diogo Tecelão: CEO and Co-founder, brings extensive knowledge in digital health and business development.

Miguel Andrade: Chief Technical Officer, focuses on technological innovations within the company.

Investment and Partnerships

Boehringer Ingelheim Venture Fund: Invests in C-mo for its potential to significantly advance patient care, particularly through innovative science and clinical applications.

Portugal Ventures: Champions start-ups with a global market appeal focusing on cutting-edge solutions.

High-Tech Gründerfonds: Offers capital and expertise to support high-tech start-ups in driving innovation.

Mission and Impact

C-mo Medical Solutions is devoted to unlocking the clinical potential of cough monitoring, catering to unmet needs in chronic cough management. The company boasts a privacy-protecting, accurate, and objective assessment of coughs, directly benefiting patient care and augmenting pharmaceutical research by providing crucial health insights.

Products and Technology

C-mo Medical Solutions provides a wearable device specifically designed for efficient cough monitoring. This technology incorporates automatic assessment and report generation tools that furnish comprehensive insights while guaranteeing patient privacy. The solutions offered by C-mo aim to expedite diagnoses and refine treatment protocols for respiratory ailments.

Industry and Size

Operating within the Medical Equipment Manufacturing industry, C-mo Medical Solutions is recognized for its medical devices tailored for cough monitoring. The company maintains a lean team, consisting of 2-10 employees, and, despite its size, has achieved considerable recognition for its innovative pursuits in digital health.

Recent Achievements and Market Position

C-mo Medical Solutions recently secured €4.1 million to enhance capabilities in cough monitoring, enabling a more extensive market presence and product enhancement. The company contends with prominent competitors in the field, including:

Hyfe: Specializes in AI-powered cough detection and analysis, prioritizing privacy and sustained patient compliance.

ResApp Health: Focuses on digital solutions for respiratory disease diagnosis and management.

Strados Labs: Offers the RESP® Biosensor for continuous monitoring of lung sounds and coughs.

Vitalograph: Supplies a broad spectrum of respiratory diagnostic tools, including spirometers widely used in clinical settings.

Competitive Edge

C-mo Medical Solutions distinguishes itself as a leader in digital health innovation focused on cough conditions. Its unique approach integrates automatic reporting and profound insights with privacy-preserving measures, solidifying its market status.

Strategic Insights

Backed by substantial financial investment and cutting-edge technology, C-mo Medical Solutions is strategically positioned to accelerate and heighten the accuracy of medical diagnostics for cough-related conditions. Their adaptable solutions have the potential to disrupt conventional methods, presenting an enhanced technological framework for respiratory diagnostics and patient monitoring.